ORBIMED ADVISORS LLC

Holdings History for Xtant Medical Holdings, Inc. - Common Stock (XTNT)

Symbol: XTNT on NYSE
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Xtant Medical Holdings, Inc. Common Stock (XTNT)

14 Apr 2025 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Xtant Medical Holdings, Inc. Common Stock (XTNT). This represents 0% ownership of the company. This is the first filing by ORBIMED ADVISORS LLC disclosing ownership of Xtant Medical Holdings, Inc. Common Stock (XTNT).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
ORBIMED ADVISORS LLC	0%		$0	0			$0.48	13D/A	10 Apr 2025	14 Apr 2025, 19:09

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025		-0.83%	$0	0	-73,114,592	-100%	$0.62	Q2 2025
31 Mar 2025	0.83%	0%	$34,363,858	73,114,592	0		$0.47	Q1 2025
31 Dec 2024	0.68%	0%	$32,389,764	73,114,592	0		$0.44	Q4 2024
30 Sep 2024	0.9%	0%	$49,425,464	73,114,592	0		$0.68	Q3 2024
30 Jun 2024	0.99%	0%	$46,062,193	73,114,592	0		$0.63	Q2 2024
31 Mar 2024	1.7%	0%	$85,544,073	73,114,592	0		$1.17	Q1 2024
31 Dec 2023	1.7%	0%	$82,619,489	73,114,592	0		$1.13	Q4 2023
30 Sep 2023	1.9%	0%	$80,426,051	73,114,592	0		$1.10	Q3 2023
30 Jun 2023	1.3%	0%	$67,989,259	73,114,592	0		$0.93	Q2 2023
31 Mar 2023	0.92%	0%	$46,610,552	73,114,592	0		$0.64	Q1 2023
31 Dec 2022	0.99%	0%	$48,255,631	73,114,592	0		$0.66	Q4 2022
30 Sep 2022	1.1%	+0%	$52,628,000	73,114,592	+170,674	+0.23%	$0.72	Q3 2022
30 Jun 2022	0.75%	0%	$37,894,000	72,943,918	0		$0.52	Q2 2022
31 Mar 2022	0.81%	+0%	$49,602,000	72,943,918	+70,424	+0.1%	$0.68	Q1 2022
31 Dec 2021	0.54%	0%	$40,809,000	72,873,494	0		$0.56	Q4 2021
30 Sep 2021	0.92%	0%	$80,890,000	72,873,494	0		$1.11	Q3 2021
30 Jun 2021	1.2%	0%	$118,784,000	72,873,494	0		$1.63	Q2 2021
31 Mar 2021	1.7%	+0%	$171,981,000	72,873,494	+70,422	+0.1%	$2.36	Q1 2021
31 Dec 2020	0.77%	+0.67%	$87,080,000	72,803,072	+63,554,394	+687%	$1.20	Q4 2020
30 Sep 2020	0.1%	0%	$7,618,000	9,248,678	0		$0.82	Q3 2020
30 Jun 2020	0.12%	+0%	$8,324,000	9,248,678	+41,666	+0.45%	$0.90	Q2 2020
31 Mar 2020	0.1%	0%	$6,169,000	9,207,012	0		$0.67	Q1 2020
31 Dec 2019	0.21%	0%	$14,731,000	9,207,012	0		$1.60	Q4 2019
30 Sep 2019	0.5%	0%	$26,148,000	9,207,012	0		$2.84	Q3 2019
30 Jun 2019	0.44%	0%	$27,621,000	9,207,012	0		$3.00	Q2 2019
31 Mar 2019	0.44%	0%	$28,081,000	9,207,012	0		$3.05	Q1 2019
31 Dec 2018	0.28%	0%	$14,823,000	9,207,012	0		$1.61	Q4 2018
30 Sep 2018	0.43%	0%	$35,447,000	9,207,012	0		$3.85	Q3 2018
30 Jun 2018	0.61%	0%	$51,099,000	9,207,012	0		$5.55	Q2 2018
31 Mar 2018	0.91%	+0.91%	$72,643,000	9,207,012	+9,207,012	NEW	$7.89	Q1 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.